For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.
Improving accessibility, affordability, and tailoring treatment and diagnostics to women’s needs are some of the crucial measures to closing the health gap for the fairer sex by 2030, said ...
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...
Morning Overview on MSN
Quantum-powered proteins could launch a shocking new biotech era
Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...
New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, delivering up to 10x performance gains on key drug discovery benchmarks and ...
This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...
An editorial published in the New England Journal of Medicine 1 referred to the Photovoltaic Retina Implant Microarray (PRIMA ...
SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.
Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results